SCHEMBL4435294

SCHEMBL4435294

NC(=O)c1ccc2c(c1)[nH]c(=O)n2C1CCN(CC(=O)N2C[C@H]3CCC[C@H]3C2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.47
YEATS4 O95619 2/20 0.47
PLD1 Q13393 10/20 0.47
PLD2 O14939 9/20 0.47
HSD11B1 P28845 1/20 0.46
DRD2 P14416 3/20 0.44
HTR1A P08908 2/20 0.44
ADRA2A P08913 2/20 0.44
HTR2A P28223 2/20 0.44
DRD3 P35462 2/20 0.44
SLC6A4 P31645 1/20 0.44
CHRM2 P08172 2/20 0.44
CHRM1 P11229 2/20 0.44
CHRM3 P20309 2/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
MLLT3 P42568 1/20 0.44
MLLT1 Q03111 1/20 0.44
YEATS2 Q9ULM3 1/20 0.44
LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438975 0.91 YEATS4 (0.49) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL4439137 0.89 YEATS4 (0.49) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL5000703 0.86 PLD2 (0.51) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL4435287 0.84 YEATS4 (0.51) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL4440298 0.83 OPRM1 (0.41) KCNH2PLD1PLD2HSD11B1DRD2
SCHEMBL4444762 0.81 OPRM1 (0.57) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL4446518 0.80 CTSS (0.44) KCNH2YEATS4PLD1PLD2HSD11B1
SCHEMBL4434701 0.79 YEATS4 (0.49) KCNH2YEATS4PLD1PLD2DRD2
SCHEMBL4444801 0.79 OPRM1 (0.42) KCNH2PLD1PLD2HSD11B1DRD2
SCHEMBL4440527 0.78 CTSS (0.42) PLD1PLD2DRD2HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121656-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE Pfizer Products Inc. (US) 2009-11-25 EP claimed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US claimed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO claimed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE SPTLC1, SPTLC2, CPT1A KCNH2 4650/4885YEATS4 1467/4885PLD1 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.